Summary Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of Medullary thyroid carcinoma (MTC) spreads early to regional lymph nodes in the neck and mediastinum and to distant sites in the liver, lungs and bones (Grauer et al., 1990) .
Medullary thyroid carcinoma (MTC) spreads early to regional lymph nodes in the neck and mediastinum and to distant sites in the liver, lungs and bones (Grauer et al., 1990) .
The aim of initial surgery is to remove all neoplastic foci. It consists of a total thyroidectomy with bilateral lymph node dissection in the neck and the upper mediastinum (Wahl & Roher, 1988) . The normalisation of the serum calcitonin (CT) level after surgery is a strong indicator that neoplastic tissue has been totally removed. However, this is achieved in only 20% of patients with clinical disease (Parmentier et al., 1985) . In others, persistently elevated CT levels indicate the presence of residual disease. If localised, this may warrant further surgery. However, a complete work-up, including ultrasonography, computerised tomography or magnetic resonance imaging and bone scintigraphy, frequently yields no positive evidence of localised tumours in these patients with elevated CT levels. Furthermore, owing to previous surgical procedures, the significance of any abnormality may be ambiguous. Scintigraphic procedures have not proved to be sensitive enough to be useful as a routine.
Selective venous sampling catheterisation appeared to be a sensitive and specific tool for localising the origin of serum CT in patients with elevated CT levels and no other evidence of disease (Ben Mrad et al., 1989; Gautvik et al., 1989; Frank-Raue et al., 1992) . However, given the slow growth rate of most MTCs, the follow-up was too short in these series to elucidate the significance of extracervical gradients and to conclude that this technique could be useful, in terms of relapse and survival rates.
The present study is based on 19 patients, with a mean follow-up of 5.5 years after selective venous catheterisation. Eight of these patients have previously been reported (Ben Mrad et al., 1989) .
Before selective venous catheterisation, all patients were subjected to a clinical examination, including chest radiography, ultrasonography of the neck and liver, computerised tomography of the neck, chest and abdomen and bone scintigraphy. This work-up only permitted the discovery of involved cervical or mediastinal lymph nodes in six patients (nos. 1, 4, 6, 13, 18 and 19) .
The selective venous sampling catheterisation procedure has already been reported (Ben Mrad et al., 1989) . It was performed by the femoral route using a Cook SF 2-cm-long catheter with a 1200 angle and one side-hole tip (Cook, SARL, Paris, France). A standard procedure was used: a mean of 25 samples was obtained for each patients from iliac veins, inferior vena cava, hepatic and renal veins, the right auricle, superior vena cava, mediastinal, brachiocephalic, internal jugular veins and the remaining thyroid veins. Peripheral venous blood samples were obtained by needle puncture of a forearm vein.
Serum CT was measured using a polyclonal antibody radioimmunoassay (Calmettes et al., 1979 ) (normal range less than 0.25 ng ml-') and, since 1986, using a monoclonal antibody immunoradiometric assay (Motte et al., 1988 ) (normal range less than lOpgmh1-). Intra-assay variability was less than 7% and inter-assay variability less than 15%. The CT gradient was expressed as the ratio of CT levels in the selective sample and in the basal peripheral sample. All gradients equal to or above 1.2 were considered as significant.
After selective venous catheterisation, 13 patients underwent further surgery, of whom six were also subjected to post-operative external radiotherapy to the neck and upper mediastinum. The other six patients did not undergo further surgery. External radiotherapy to the neck and mediastinum was performed in two patients (nos. 17 In patient 15, whose surgical procedure was complete, no CT gradient was found. In the other 18 patients, significant gradients, ranging from 1.2 to 8.3, were found in the neck and/or the upper mediastinum. In addition, gradients were found at distant sites in five patients. Selective venous catheterisation gave evidence of a gradient at the site of the abnormality in all six patients in whom the previous work-up had shown abnormalities, and in two of them (nos. 4 and 18) also at sites where no abnormality had been found. (Table II) Thirteen patients with CT gradients ranging from 1.3 to 8.3 in the neck and/or mediastinum underwent further surgery.
Surgery after venous catheterisation
In one patient (no. 12) with a CT gradient equal to 1.3, no tumour tissue was found; 3.3 years after venous catheterisation, the serum CT level is stable and there is no other evidence of disease.
In the other 12 patients, tumour foci were found at all the sites of the gradients. Among the nine patients with no distant gradient, the CT level normalised only in patient 8 after excision of a residual thyroid lobe, which contained a MTC focus, whereas all the dissected lymph nodes were free of disease. The CT level decreased in five patients and did not change post-operatively in the other three patients. Six of these patients subsequently received irradiation to the neck and upper mediastinum, but no further decrease in serum CT was observed. In these nine patients, with a mean followup of 5.3 years (1.1 -12.3 years) after venous catheterisation, no neck relapse or distant metastasis occurred. Among the three patients who also had distant gradients, the CT level did not decrease after surgery. No relapse occurred in the neck, but all three patients developed distant metastases at the sites of the gradients 2-5 years after venous catheterisation.
Six patients were not reoperated after venous catheterisation (Table III) Patient 15 with no CT gradient has stable disease 1.6 years after venous catheterisation. The other five patients had gradients in the neck and/or in the mediastinum, ranging from 1.2 to 2.5. Two patients (nos. 16 and 18) were not operated on again for distant gradients and distant metastases emerged clinically at the sites of the gradients 1-1.5 years after venous catheterisation. The other three patients (nos. 14, 17 and 19) had no distant gradient. They refused further surgery. Patient 14 
Discussion
The present data confirm that, in patients with a high serum CT level after surgery, selective venous catheterisation is the most sensitive and the most specific method for the localisation of MTC tissue (Table IV) (Ben Mrad et al., 1989; Gautvik et al., 1989; Frank-Raue et al., 1992) . It was possible to localise small foci of MTC even in patients with no other evidence of disease. Venous catheterisation detected all neoplastic foci found at further neck surgery. Venous catheterisation showed CT gradients in the neck or mediastinum, and in some patients at distant sites, even in those with relatively low basal CT levels. Therefore there is no cut-off value for the CT level below or above which neoplastic foci in the neck or at distant sites may be assumed to exist. This is in agreement with the findings of a previous study (Gautvik et al., 1989) . CT gradients were frequently found in the mediastinum.
Venous catheterisation is particularly interesting in this location, which is frequently involved (Wahl & Roher, 1988 Of the three patients with cervical gradients only but who refused further surgery, one developed a mediastinal recurrence despite radiotherapy and which led to death and the other two had progressive disease.
In the nine patients without distant gradients, despite the excision of tumour foci at the sites of the gradients, the CT level normalised post-operatively in only one patient who had no lymph node metastasis and decreased in the other five patients. This low cure rate is in agreement with the findings of some series (Van Heerden et al., 1990) , but is lower than in series using microsurgical reoperation (Tisell et al., 1986; Frank-Raue et al., 1992) in which a biochemical cure in 21-36% of patients has been reported. However, none of our patients developed a neck recurrence. Therefore, they may be controlled for a long period of time by external irradiation or, because of the slow growth rate of most MTCs (Van Heerden et al., 1990) , the clinical emergence of the disease may occur years later.
In conclusion, selective venous sampling catheterisation is the most sensitive method available for the localisation of persisting MTC after initial surgery and can aid decisions regarding further therapy. In fact, one of the main benefits of this procedure is the detection of distant spread. In these patients, reoperation is not indicated, but a strict follow-up is warranted and can be guided by venous catheterisation.
